The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
Open accessAbstract
BACKGROUND: The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non-intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing deviations for medical reasons) with beta-lactam monotherapy, beta-lactam-macrolide combination therapy, or fluoroquinolone monotherapy. METHODS: In a cluster-randomized, crossover trial with strategies rotated in 4-month periods, we tested the noninferiority of the beta-lactam strategy to the beta-lactam-macrolide and fluoroquinolone strategies with respect to 90-day mortality, in an intention-to-treat analysis, using a noninferiority margin of 3 percentage points and a two-sided 90% confidence interval. RESULTS: A total of 656 patients were included during the beta-lactam strategy periods, 739 during the beta-lactam-macrolide strategy periods, and 888 during the fluoroquinolone strategy periods, with rates of adherence to the strategy of 93.0%, 88.0%, and 92.7%, respectively. The median age of the patients was 70 years. The crude 90-day mortality was 9.0% (59 patients), 11.1% (82 patients), and 8.8% (78 patients), respectively, during these strategy periods. In the intention-to-treat analysis, the risk of death was higher by 1.9 percentage points (90% confidence interval [CI], -0.6 to 4.4) with the beta-lactam-macrolide strategy than with the beta-lactam strategy and lower by 0.6 percentage points (90% CI, -2.8 to 1.9) with the fluoroquinolone strategy than with the beta-lactam strategy. These results indicated noninferiority of the beta-lactam strategy. The median length of hospital stay was 6 days for all strategies, and the median time to starting oral treatment was 3 days (interquartile range, 0 to 4) with the fluoroquinolone strategy and 4 days (interquartile range, 3 to 5) with the other strategies. CONCLUSIONS: Among patients with clinically suspected CAP admitted to non-ICU wards, a strategy of preferred empirical treatment with beta-lactam monotherapy was noninferior to strategies with a beta-lactam-macrolide combination or fluoroquinolone monotherapy with regard to 90-day mortality. (Funded by the Netherlands Organization for Health Research and Development; CAP-START ClinicalTrials.gov number, NCT01660204.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Consort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510
Lim, W. S. (2003) · Thorax · doi:10.1136/thorax.58.5.377 · Cited by 3,070
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J., Levy, M. L., et al. (2009) · Thorax · doi:10.1136/thx.2009.121434 · Cited by 1,420
Clinical and economic burden of community-acquired pneumonia among adults in Europe
Welte, T., Torres, A., & Nathwani, D. (2012) · Thorax · doi:10.1136/thx.2009.129502 · Cited by 1,033
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
Multiple Imputation with Diagnostics (mi) in R: Opening Windows into the Black Box
Su, Y.-S., Gelman, A., Hill, J., & Yajima, M. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i02 · Cited by 645
Malhotra-Kumar, S., Lammens, C., Coenen, S., Van Herck, K., & Goossens, H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60235-9 · Cited by 545
Penalized Survival Models and Frailty
Therneau, T. M., Grambsch, P. M., & Pankratz, V. S. (2003) · Journal of Computational and Graphical Statistics · doi:10.1198/1061860031365 · Cited by 481
Kleinman, L. C., & Norton, E. C. (2009) · Health Services Research · doi:10.1111/j.1475-6773.2008.00900.x · Cited by 292
Wunderink, R. G., & Waterer, G. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1214869 · Cited by 267
Garin, N., Genné, D., Carballo, S., Chuard, C., Eich, G., Hugli, O., Lamy, O., Nendaz, M., Petignat, P.-A., Perneger, T., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4887 · Cited by 242
Schembri, S., Williamson, P. A., Short, P. M., Singanayagam, A., Akram, A. R., Taylor, J., Singanayagam, A., Hill, A. T., & Chalmers, J. D. (2013) · BMJ · doi:10.1136/bmj.f1235 · Cited by 135
Epidemic Q Fever in Humans in the Netherlands
van der Hoek, W., Morroy, G., Renders, N. H. M., Wever, P. C., Hermans, M. H. A., Leenders, A. C. A. P., & Schneeberger, P. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4315-1_17 · Cited by 129
Confounding and indication for treatment in evaluation of drug treatment for hypertension
Grobbee, D. E., & Hoes, A. W. (1997) · BMJ · doi:10.1136/bmj.315.7116.1151 · Cited by 129
Incidence and Cost of Pneumonia in Medicare Beneficiaries
Parks, C. L., Ryan, M., Chapman, J. D., Stason, W. B., Tompkins, C. P., Suaya, J. A., Polsky, D. E., Mannino, D. M., & Shepard, D. S. (2012) · CHEST Journal · doi:10.1378/chest.11-1160 · Cited by 116
Yu, H., Rubin, J. L., Dunning, S. C., Li, S., & Sato, R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04208.x · Cited by 81
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Klugman, K. P. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00400402 · Cited by 74
Wiersinga, W. J., Bonten, M. J. M., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B. J., Schouten, J. A., Degener, J. E., Janknegt, R., Verheij, T. J., et al. (2012) · PubMed · Cited by 73
Self-citationDiagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia
Huijts, S. M., Pride, M. W., Vos, J. M. I., Jansen, K. U., Webber, C., Gruber, W. C., Boersma, W. G., Snijders, D., Kluytmans, J. A. J. W., van der Lee, I., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00137412 · Cited by 72
Self-citationThe Design of Cluster Randomized Crossover Trials
Rietbergen, C., & Moerbeek, M. (2011) · Journal of Educational and Behavioral Statistics · doi:10.3102/1076998610379136 · Cited by 56
Wunderink, R. G., & WATERER, G. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1402692 · Cited by 54
Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/591411 · Cited by 48
Dr. William H. Stewart: Mistaken or Maligned?
Spellberg, B. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589579 · Cited by 46
Powers, J. H. (2008) · Clinical Infectious Diseases · doi:10.1086/533442 · Cited by 8
Cited by
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Prina, E., Ranzani, O. T., & Torres, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60733-4 · Cited by 516
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
Ferreira-Coimbra, J., Sarda, C., & Rello, J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01248-7 · Cited by 255
Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure.
Baggs, J., Jernigan, J. A., Halpin, A. L., Epstein, L., Hatfield, K. M., & McDonald, L. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix947 · Cited by 190
Rottier, W. C., van Werkhoven, C. H., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van de Garde, E. M., van Hees, B. C., Kluytmans, J. A. J. W., Kuck, E. M., van der Linden, P. D., Prins, J. M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.03.023 · Cited by 22
Self-citation
Metadata
- Authors
- Postma, D. F., van Werkhoven, C. H., van Elden, L. J. R., Thijsen, S. F. T., Hoepelman, A. I. M., Kluytmans, J. A. J. W., Boersma, W. G., Compaijen, C. J., van der Wall, E., Prins, J. M., Oosterheert, J. J., & Bonten, M. J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-02
- Volume
- 372
- Issue
- 14
- Pages
- 1312-1323
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150772812
- Cited by
- 376
- References
- 28
- FWCI
- 39.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.